2019 they were doing multi million quarters with something like 12 or 13 quarter over quarter growth. It was very impressive and the main reason it attracted so many investors at the time. Then stem cells started taking a hit, hindenburg struck, and management was just smug enough to think it wouldn't matter, that it was nothing to concern themselves with, and it's basically been that same story ever since. With a huge failure with a Chinese covid test thrown in for good measure. They've taken a few steps since to "right" the ship but no where near enough to put it back on track (yet).
One thing I've learned about pred is that despite the gloom, they some how mange to find funding to keep things rolling. Unfortunately, the revenue streams we have all hoped for, by all appearances, seem to be nothing burgers. We'll see what the the next one is soon enough I'm sure.
News 
Market Data 
Discover 
